"I'm lucky to be alive": woman's warning over black-market weight-loss jabs

An insulin pen with an injection port; illustrative, not the products in the story. Photo: Marius Vassnes · CC BY-SA 4.0 · Wikimedia Commons
A woman who collapsed after taking an unlicensed weight-loss injection bought on the black market has warned others to stay away from the products, saying: "I am the luckiest person to be alive."
Kay Roscoe, 38, from Birkenhead, had been injecting a substance sold as retatrutide — nicknamed "reta" — for about two months before she fell seriously ill in October. When she failed to answer her phone before a planned dinner, a friend found her at home unable to speak or stand. "I was frothing at the mouth, not responsive at all," she said, recounting what she was later told. She has no memory of the episode and took more than an hour to regain consciousness in hospital.
Tests confirmed severe hypoglycaemia — dangerously low blood sugar — and her medical records attributed the episode to an unlicensed weight-loss injection. Doctors warned she could have died had her friend arrived just half an hour later. Weeks on, she still suffers extreme fatigue, and further tests have shown signs of liver damage and high cholesterol, neither of which she had before. "I just feel run down and drained. My body feels all over the place," she said.
Roscoe, a former regular gym-goer, bought the injections from a friend after seeing weight-loss posts on social media, and believed they were legitimate after scanning a QR code on the pen that led to what looked like a pharmaceutical website. She lost a "drastic amount" of weight within weeks but was hardly eating. She now plans to return to the gym and eat healthily. "Please, everyone, stop taking a needle to be skinny. Imagine not waking up, like I nearly didn't," she said.
Retatrutide is an experimental obesity drug being developed by Eli Lilly. Unlike licensed weight-loss medicines such as Wegovy and Mounjaro, which act on one or two hormone receptors, it targets three — earning it the name "triple G" — and is available legally only through clinical trials, with a US approval application planned early next year. The company said counterfeit and black-market versions are "unverified, unregulated and potentially dangerous — in some cases, deadly", and that it is working with the UK medicines regulator, the MHRA, police and social media platforms to remove illegal products. The MHRA has seized products claiming to contain retatrutide.
Dr Nas Khattak, a Chester-based research doctor who has worked on weight-loss drug trials, said substances are advertised through messaging apps, bodybuilding forums and private sellers: "You cannot verify the dose, purity, sterility, or even the contents. If something goes wrong there is no proper medical oversight." He described treating a young woman who needed intensive care after an injection bought from a beautician, and said using such products "really does feel like a roll of the dice". Warning signs requiring urgent medical attention include severe abdominal pain, persistent vomiting or diarrhoea, pain beneath the right ribs, yellowing of the eyes and significant changes in mood.